Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Signature construction and molecular subtype identification based on liver-specific genes for prediction of prognosis, immune activity, and anti-cancer drug sensitivity in hepatocellular carcinoma

Fig. 2

HCC subtype-specific pathways identified through GSEA analyses. A–C GSEA between C1 and C2, C1 and C3, and C2 and C3 subtypes, respectively. D The intersection of pathways among different HCC subtypes. E The HCC subtype-specific pathways comparing with other subtypes

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us